These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37799636)

  • 21. Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review.
    Abdelwadoud M; Mattingly TJ; Seguí HA; Gorman EF; Perfetto EM
    Patient; 2021 Sep; 14(5):471-484. PubMed ID: 33372245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs.
    Ferguson C; Higgs P; Olsen A
    Nurs Health Sci; 2015 Dec; 17(4):539-41. PubMed ID: 26306397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.
    Howell J; Traeger MW; Williams B; Layton C; Doyle JS; Latham N; Draper B; Bramwell F; Membrey D; McPherson M; Roney J; Stoové M; Thompson AJ; Hellard ME; Pedrana A
    J Viral Hepat; 2022 May; 29(5):375-384. PubMed ID: 35274403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries.
    Ford N; Wiktor S; Kaplan K; Andrieux-Meyer I; Hill A; Radhakrishnan P; Londeix P; Forette C; Momenghalibaf A; Verster A; Swan T
    Int J Drug Policy; 2015 Nov; 26(11):1088-93. PubMed ID: 26074094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.
    Mafirakureva N; Stone J; Fraser H; Nzomukunda Y; Maina A; Thiong'o AW; Kizito KW; Mucara EWK; González Diaz CI; Musyoki H; Mundia B; Cherutich P; Nyakowa M; Lizcano J; Chhun N; Kurth A; Akiyama MJ; Waruiru W; Bhattacharjee P; Cleland C; Donchuk D; Luhmann N; Loarec A; Maman D; Walker J; Vickerman P
    Addiction; 2022 Feb; 117(2):411-424. PubMed ID: 34184794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.
    Madden A; Hopwood M; Neale J; Treloar C
    Harm Reduct J; 2018 Aug; 15(1):42. PubMed ID: 30111327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis.
    Greenwald ZR; Bouck Z; McLean E; Mason K; Lettner B; Broad J; Dodd Z; Nassau T; Scheim AI; Werb D
    J Viral Hepat; 2023 Feb; 30(2):160-171. PubMed ID: 36461705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.
    Deyessa N; Senbete B; Abdo A; Mundia BM
    Harm Reduct J; 2020 Sep; 17(1):61. PubMed ID: 32894153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.
    Goutzamanis S; Spelman T; Harney B; Dietze P; Stoove M; Higgs P; Thompson A; Doyle JS; Hellard M
    J Viral Hepat; 2021 Jul; 28(7):1068-1077. PubMed ID: 33880820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs.
    Asher AK; Portillo CJ; Cooper BA; Dawson-Rose C; Vlahov D; Page KA
    Subst Use Misuse; 2016 Jul; 51(9):1218-23. PubMed ID: 27219274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study.
    Damas J; Storm M; Pandey LR; Marrone G; Deuba K
    Ther Adv Infect Dis; 2021; 8():20499361211062107. PubMed ID: 34881024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilizing patient perception of group treatment in exploring medication adherence, social support, and quality of life outcomes in people who inject drugs with hepatitis C.
    Howard KA; Rennert L; Pericot-Valverde I; Heo M; Norton BL; Akiyama MJ; Agyemang L; Litwin AH
    J Subst Abuse Treat; 2021 Jul; 126():108459. PubMed ID: 34116813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key findings from a national enhanced HIV surveillance system: 2010 - 2012.
    Tarasuk J; Ogunnaike-Cooke S; Archibald C; MacLean R; Bennett R; Kim J; Malloch L;
    Can Commun Dis Rep; 2014 Nov; 40(18):397-407. PubMed ID: 29769871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.
    Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore GJ; Grebely J
    Clin Infect Dis; 2021 Jul; 73(1):e69-e78. PubMed ID: 32421194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
    Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
    MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ
    Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study.
    Goutzamanis S; Doyle JS; Horyniak D; Higgs P; Hellard M;
    Int J Drug Policy; 2021 Jan; 87():102983. PubMed ID: 33126166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).
    Barré T; Marcellin F; Di Beo V; Delorme J; Rojas Rojas T; Mathurin P; Protopopescu C; Bailly F; Coste M; Authier N; Carrieri MP; Rolland B
    Addiction; 2020 Mar; 115(3):573-582. PubMed ID: 31595554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.